Department of transfusion medicine, General Hospital Pula, Pula, Croatia.
Biochem Med (Zagreb). 2020 Feb 15;30(1):011002. doi: 10.11613/BM.2020.011002. Epub 2019 Dec 15.
Rejection of the sample with repeated blood withdrawal is always an unwanted consequence of sample nonconformity and preanalytical errors, especially in the most vulnerable population - children. Here is presented a case with unexpected abnormal coagulation test results in a 2-year-old child with no previously documented coagulation disorder. Child is planned for tympanostomy tubes removal under the anaesthesia driven procedure, and preoperative coagulation tests revealed prolonged prothrombin time, activated partial thromboplastin time and thrombin time, with fibrinogen and antithrombin within reference intervals. From the anamnestic and clinical data, congenital coagulation disorder was excluded, and with further investigation, sample mismatch, clot presence and accidental ingestion of oral anticoagulant, heparin contamination or vitamin K deficiency were excluded too. Due to suspected EDTA carryover during blood sampling another sample was taken the same day and all tests were performed again. The results for all tests were within reference intervals confirming EDTA effect on falsely prolongation of the coagulation times in the first sample. This case can serve as alert to avoid unnecessary loss in terms of blood withdrawal repetitions and discomfort of the patients and their relatives, tests repeating, prolonging medical procedures, and probably delaying diagnosis or proper medical treatment. It is the responsibility of the laboratory specialists to continuously educate laboratory staff and other phlebotomists on the correct blood collection as well as on its importance for the patient's safety.
由于反复采血导致的样本被拒通常是样本不合格和分析前误差的不良后果,尤其是在最脆弱的人群——儿童中。本文报道了一例 2 岁儿童在无先前记录的凝血障碍情况下出现意外异常凝血检测结果的情况。该儿童计划在麻醉下进行鼓室置管术,术前凝血检测显示凝血酶原时间、活化部分凝血活酶时间和凝血酶时间延长,纤维蛋白原和抗凝血酶在参考范围内。根据病史和临床数据,排除了先天性凝血障碍,进一步调查排除了样本不匹配、凝血块存在、意外摄入口服抗凝剂、肝素污染或维生素 K 缺乏。由于怀疑在采血过程中存在 EDTA 携带,当天再次采集了另一份样本,并重新进行了所有检测。所有检测结果均在参考范围内,证实了 EDTA 对第一份样本中凝血时间假性延长的影响。该病例可作为警示,以避免因重复采血、患者及其亲属不适、重复检测、延长医疗程序以及可能延误诊断或适当治疗而造成不必要的损失。实验室专家有责任不断教育实验室工作人员和其他采血人员正确采血及其对患者安全的重要性。